|1.||Szekeres-Bartho, Julia: 5 articles (06/2015 - 04/2005)|
|2.||Check, J H: 4 articles (01/2015 - 01/2005)|
|3.||Polgar, Beata: 3 articles (06/2015 - 08/2010)|
|4.||Check, Jerome H: 3 articles (05/2014 - 08/2007)|
|5.||Hudić, Igor: 2 articles (06/2015 - 01/2009)|
|6.||Cohen, Rachael: 2 articles (05/2014 - 05/2014)|
|7.||Sarumi, Mojirayo: 2 articles (05/2014 - 05/2014)|
|8.||Szekeres-Bartho, J: 2 articles (06/2011 - 06/2009)|
|9.||Sansoucie, L: 2 articles (01/2009 - 01/2007)|
|10.||Rüdel, R: 2 articles (07/2000 - 01/2000)|
01/01/2004 - "The clinical tolerability and the efficacy of low molecular weight heparins has established that inhibition of further thrombin generation, by blocking factor Xa alone can be an effective way of preventing thrombus growth without inactivating thrombin. "
01/01/2002 - "The clinical tolerability and the efficacy of low molecular weight heparins led to the concept that inhibition of further thrombin generation, by blocking factor Xa alone, can be an effective way of preventing thrombus growth without inactivating thrombin. "
05/01/2014 - "Mifepristone causing complete remission of rapidly advancing leukemia with measurement of progesterone-induced blocking factor."
01/01/2007 - "Multiple human leukemia cell lines were evaluated for mRNA expression of an immunomodulatory protein called the progesterone-induced blocking factor (PIBF) that suppresses natural killer (NK) cell activity during normal pregnancy. "
08/01/2007 - "Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone."
01/01/1979 - "This study has indicated that the cell mediated antitumor immune response of rats immunized with living tumor cells and the blocking factor in serum of rats with progressively growing tumors may be demonstrated by the LAI assay with incubation time prolonged to 20 hr (LAI assay-IT20). "
01/01/1976 - "In vitro studies demonstrated the evidence of sensitization of the patient against his own tumor, removal of blocking factor by the thoracic duct fistual from the circulation."
01/01/1990 - "Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patients."
01/01/1985 - "aureus indicate that specific blocking factor removal by plasma adsorption may not be the mechanism for causing tumor destruction. "
04/01/1984 - "It is our belief that failure to sufficiently concentrate the antibody in the tumor before operation was due to blocking factor in the serum of the patient. "
|4.||Habitual Abortion (Recurrent Miscarriage)
01/01/1984 - "The study deals with 9 women with recurrent abortions who do not possess the blocking factor which is present during normal pregnancy and which inhibits, nonspecifically, a cellular cytotoxicity reaction in vitro. "
12/01/1983 - "We propose that HLA typing, MLC reactions, and blocking factor studies will serve as useful laboratory indices in future clinical studies of immunogenetical disorders associated with idiopathic habitual abortion."
05/01/1991 - "The activity of the blocking factor (BF) was studied in 88 patients affected by recurrent abortion syndrome (RAS) by means of the determination of lymphocyte proliferation rate (LPR) in one-way mixed maternal-paternal lymphocyte cultures (MLC). "
11/01/1989 - "Up to now the only effective therapy for recurrent abortion syndrome due to the absence of the so-called blocking-factor has been active immunotherapy with partner or third-party donor mononucleates. "
01/01/1982 - "The women studied with recurrent abortions never possessed the Blocking Factor present in the serum of pregnant women, able to inhibit a cellular cytotoxicity reaction in vitro. "
|5.||Spontaneous Abortion (Miscarriage)
10/01/1990 - "Although the pathophysiological mechanisms leading to recurrent spontaneous abortion are still not fully understood, treatment schemes based on immunological principles have been advocated in recent years claiming that the production of the so-called blocking factor is being specifically stimulated. "
05/01/1983 - "The absence of the 'blocking factor' could be used as a clinical test to predict spontaneous abortion."
01/01/2015 - "This study seeks to establish progesterone and progesterone-induced blocking factor (PIBF) levels as predictors of subsequent completed miscarriage among women presenting with threatened miscarriage between 6 and 10 weeks of gestation. "
10/01/2013 - "The majority of cases of unexplained recurrent spontaneous abortion (RSA) remains unclear and is found to be associated with alloimmune antibodies termed as mixed lymphocyte reaction blocking factor (MLR-Bf). "
01/01/2009 - "Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion."
|3.||Mifepristone (RU 486)
|6.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|7.||Immunoglobulin G (IgG)
|10.||Sodium Channels (Sodium Channel)
|1.||Drug Therapy (Chemotherapy)
|2.||Self Care (Care, Self)
|5.||Induced Abortion (Induced Abortions)